Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Laurence Charney Insider Profile
11 Followers
Laurence Charney, Director at TG Therapeutics, holds 161.00K shares in TG Therapeutics (Ticker: TGTX), holds 21.43K shares in Iconix Brand (Ticker: ICON).
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-61.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Laurence Charney holds in companies
Most Profitable Insider Trade
The most profitable trade made by Laurence Charney
Laurence Charney's Trading History
TG Therapeutics
Jun 24, 2020
Director
Uninformative Buy
―
$4.88M
Iconix Brand
Jan 03, 2013
Director
Uninformative Buy
―
$19.61K
List of latest transactions for each holding click on a transaction to see Laurence Charney's performance on stock
You May Also Like
Laurence Charney insider profile FAQ
What is the percentage of profitable transactions made by Laurence Charney?
The percentage of profitable transactions made by Laurence Charney is 0%.
What is the average return per transaction made by Laurence Charney?
The average return per transaction made by Laurence Charney is -61.00%.
What stocks does Laurence Charney hold?
Laurence Charney holds: TGTX, ICON stocks.
What was Laurence Charney’s latest transaction?
Laurence Charney latest transaction was an Uninformative Buy of ―.
What was Laurence Charney's most profitable transaction?
Laurence Charney’s most profitable transaction was an Informative Sell of TGTX stock on April 4, 2017. The return on the trade was -28.00%.
What is Laurence Charney's role in TG Therapeutics?
Laurence Charney's role in TG Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.